AR040027A1 - Inhibidores de la transcriptasa inversa no nucleosidos - Google Patents
Inhibidores de la transcriptasa inversa no nucleosidosInfo
- Publication number
- AR040027A1 AR040027A1 ARP030101708A ARP030101708A AR040027A1 AR 040027 A1 AR040027 A1 AR 040027A1 AR P030101708 A ARP030101708 A AR P030101708A AR P030101708 A ARP030101708 A AR P030101708A AR 040027 A1 AR040027 A1 AR 040027A1
- Authority
- AR
- Argentina
- Prior art keywords
- alkyl
- cooh
- formula
- optionally substituted
- cycloalkyl
- Prior art date
Links
- 239000003112 inhibitor Substances 0.000 title 1
- 238000003874 inverse correlation nuclear magnetic resonance spectroscopy Methods 0.000 title 1
- 125000004169 (C1-C6) alkyl group Chemical group 0.000 abstract 19
- 125000000896 monocarboxylic acid group Chemical group 0.000 abstract 8
- 125000003118 aryl group Chemical group 0.000 abstract 4
- 125000000753 cycloalkyl group Chemical group 0.000 abstract 4
- 125000000623 heterocyclic group Chemical group 0.000 abstract 4
- 125000004178 (C1-C4) alkyl group Chemical group 0.000 abstract 3
- 229910052760 oxygen Inorganic materials 0.000 abstract 3
- 229910052717 sulfur Inorganic materials 0.000 abstract 3
- 125000004191 (C1-C6) alkoxy group Chemical group 0.000 abstract 2
- 125000000217 alkyl group Chemical group 0.000 abstract 2
- 229910052736 halogen Inorganic materials 0.000 abstract 2
- 150000002367 halogens Chemical group 0.000 abstract 2
- 125000005842 heteroatom Chemical group 0.000 abstract 2
- 229910052757 nitrogen Inorganic materials 0.000 abstract 2
- 125000001424 substituent group Chemical group 0.000 abstract 2
- NAWXUBYGYWOOIX-SFHVURJKSA-N (2s)-2-[[4-[2-(2,4-diaminoquinazolin-6-yl)ethyl]benzoyl]amino]-4-methylidenepentanedioic acid Chemical compound C1=CC2=NC(N)=NC(N)=C2C=C1CCC1=CC=C(C(=O)N[C@@H](CC(=C)C(O)=O)C(O)=O)C=C1 NAWXUBYGYWOOIX-SFHVURJKSA-N 0.000 abstract 1
- 125000006273 (C1-C3) alkyl group Chemical group 0.000 abstract 1
- -1 (C2-4) alkenyl -COOH Chemical group 0.000 abstract 1
- 125000006645 (C3-C4) cycloalkyl group Chemical group 0.000 abstract 1
- JCXJVPUVTGWSNB-UHFFFAOYSA-N Nitrogen dioxide Chemical compound O=[N]=O JCXJVPUVTGWSNB-UHFFFAOYSA-N 0.000 abstract 1
- 125000005119 alkyl cycloalkyl group Chemical group 0.000 abstract 1
- MDFFNEOEWAXZRQ-UHFFFAOYSA-N aminyl Chemical compound [NH2] MDFFNEOEWAXZRQ-UHFFFAOYSA-N 0.000 abstract 1
- 229910052799 carbon Inorganic materials 0.000 abstract 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 125000001188 haloalkyl group Chemical group 0.000 abstract 1
- 125000005843 halogen group Chemical group 0.000 abstract 1
- 229910052739 hydrogen Inorganic materials 0.000 abstract 1
- 229940002612 prodrug Drugs 0.000 abstract 1
- 239000000651 prodrug Substances 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
- C07D471/14—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Virology (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Public Health (AREA)
- AIDS & HIV (AREA)
- Engineering & Computer Science (AREA)
- Tropical Medicine & Parasitology (AREA)
- Molecular Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Abstract
Reivindicación 1: Un compuesto representado por la fórmula (1) en donde R2 se selecciona de H, alquilo C1-4, halo, haloalquilo, OH, alcoxi C1-6, NH(alquilo C1-4) o N (alquilo C1-4)2; R4 es H o Me; R5 es H o Me; R11 es H, alquilo C1-4, cicloalquilo C3-4 y alquil (C1-4)-cicloalquilo (C3-4); A es una cadena de conexión de alquilo C1-3; B es O o S; n es 0 o 1; en donde, cuando n es 0, el anillo C es arilo de 6 o 10 miembros o un heterociclo de 5 o 6 miembros con 1 a 4 heteroátomos seleccionados de O, N, y S, estando dicho arilo y dicho heterociclo opcionalmente sustituidos con 1 a 4 sustituyentes seleccionados de: halógeno y alquilo C1-6 opcionalmente sustituido con OH; y E se selecciona de : (i) CONR12R13, en donde R12 y R13, cada uno independientemente, es H, SO2(alquilo C1-6), alquil (C1-6)-COOH, alquil (C1-6)-cicloalquilo (C3-7), estando dicho cicloalquilo opcionalmente sustituido con COOH; (ii) CONHNR14R15, en donde R134 y R15, cada uno independientemente, es H o alquilo C1-6, opcionalmente sustituido con COOH; (iii) NR16COR17, en donde R16 es H o alquilo C1-6, opcionalmente sustituido con COOH o aril (C6-10)-COOH; y R17 es alquenil (C2-4)-COOH, cicloalquil (C3-7)-COOH, NH-alquil(C1-6)-COOH; alquilo C1-6 opcionalmente sustituido con COOH; o alquil (C1-6)-cicloalquilo (C3-7), estando dicho cicloalquilo opcionalmente sustituido con COOH; (iv) NR18SO2alquilo (C1-6), en donde R18 es H o alquilo C1-6; (v) SO2NR19R20, en donde R19 es H o alquilo C1-6; y R20 es alquilo C1-6, opcionalmente sustituido con COOH; y (vi) SO2R21, en donde R21 es alquilo C1-6; o cuando n es 1, el anillo C es como se define anteriormente; y E es un enlace sencillo o un grupo de conexión seleccionado (vii) fórmula (2); (viii) fórmula (3) en donde R22 es H o alquilo C1-6; (ix) fórmula (4) en donde R23 es H o alquilo C16; (x) fórmula (5) en donde R24 es H o alquilo C1-6; (xi) fórmula (6) en donde R25 es H o alquilo C1-6; (xii) fórmula (7) en donde R26 y R27 es cada uno H, o alquilo C1-6; (xiii) fórmula (8) en donde R28 es H o alquilo C1-6; (xiv) fórmula (9), (xv) fórmula (10) en donde R29 es H o alquilo C1-6; y (xvi) fórmula (11) y el anillo D es un arilo de 6 o 10 miembros o un heterociclo de 5 o 6 miembros con 1 a 4 heteroátomos seleccionados de: O, N y S, estando dicho arilo y dicho heterociclo opcionalmente sustituidos con 1 a 5 sustituyentes, seleccionados de: halógeno, NH2, NO2, COOH, OH, COO-alquilo(C1-6), alcoxi C1-6, alquenil (C2-4)-COOH, cicloalquil (C3-7)-COOH y alquilo C1-6, opcionalmente sustituido con COOH u OH; o una sal o un profármaco del mismo.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US38088602P | 2002-05-16 | 2002-05-16 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR040027A1 true AR040027A1 (es) | 2005-03-09 |
Family
ID=29550032
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP030101708A AR040027A1 (es) | 2002-05-16 | 2003-05-16 | Inhibidores de la transcriptasa inversa no nucleosidos |
Country Status (28)
| Country | Link |
|---|---|
| US (1) | US6806265B2 (es) |
| EP (1) | EP1506195B1 (es) |
| JP (1) | JP4230448B2 (es) |
| KR (1) | KR20050008716A (es) |
| CN (1) | CN1318421C (es) |
| AR (1) | AR040027A1 (es) |
| AT (1) | ATE412653T1 (es) |
| AU (1) | AU2003229186A1 (es) |
| BR (1) | BR0310033A (es) |
| CA (1) | CA2485916C (es) |
| DE (1) | DE60324418D1 (es) |
| EA (1) | EA009178B1 (es) |
| EC (1) | ECSP045432A (es) |
| ES (1) | ES2315492T3 (es) |
| HR (1) | HRP20041065A2 (es) |
| IL (1) | IL163753A0 (es) |
| MX (1) | MXPA04010409A (es) |
| MY (1) | MY134646A (es) |
| NO (1) | NO20044104L (es) |
| NZ (1) | NZ536736A (es) |
| PE (1) | PE20040365A1 (es) |
| PL (1) | PL371663A1 (es) |
| RS (1) | RS98004A (es) |
| TW (1) | TW200404071A (es) |
| UA (1) | UA79285C2 (es) |
| UY (1) | UY27809A1 (es) |
| WO (1) | WO2003097644A2 (es) |
| ZA (1) | ZA200406912B (es) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0302094D0 (en) | 2003-01-29 | 2003-02-26 | Pharmagene Lab Ltd | EP4 receptor antagonists |
| EP1610797A1 (en) * | 2003-03-27 | 2006-01-04 | Boehringer Ingelheim International GmbH | Antiviral combination of nevirapine and a further antiretroviral compound |
| US7348338B2 (en) | 2003-07-17 | 2008-03-25 | Plexxikon, Inc. | PPAR active compounds |
| RU2356889C2 (ru) * | 2003-07-17 | 2009-05-27 | Плекссикон, Инк. | Соединения, являющиеся активными по отношению к рецепторам, активируемым пролифератором пероксисом |
| GB0324269D0 (en) | 2003-10-16 | 2003-11-19 | Pharmagene Lab Ltd | EP4 receptor antagonists |
| DE102004051277A1 (de) * | 2004-10-21 | 2006-04-27 | Merck Patent Gmbh | Heterocyclische Carbonylverbindungen |
| EP1819673A2 (en) * | 2004-11-30 | 2007-08-22 | Plexxikon, Inc. | Indole derivatives for use as ppar active compounds |
| BRPI0615948A2 (pt) * | 2005-09-07 | 2011-05-31 | Plexxikon Inc | composto ativo de ppar, sua composição, seu kit e seu uso |
| SG165362A1 (en) * | 2005-09-07 | 2010-10-28 | Plexxikon Inc | Ppar active compounds |
| EP1931658A2 (en) * | 2005-09-07 | 2008-06-18 | Plexxikon, Inc. | 1 , 4 and 1 , 5-disubstituted indole derivatives for use as ppar active compounds |
| US8492428B2 (en) | 2005-09-20 | 2013-07-23 | Mayo Foundation For Medical Education And Research | Small-molecule botulinum toxin inhibitors |
| PE20090159A1 (es) * | 2007-03-08 | 2009-02-21 | Plexxikon Inc | COMPUESTOS DERIVADOS DE ACIDO INDOL-PROPIONICO COMO MODULADORES PPARs |
| EP3223821A1 (de) | 2014-11-25 | 2017-10-04 | Bayer Pharma Aktiengesellschaft | Substituierte pyridobenzodiazepinon-derivate und ihre verwendung |
| CN115745910B (zh) | 2017-07-21 | 2025-05-27 | 安塔比奥公司 | 化学化合物 |
| CR20200464A (es) | 2018-03-08 | 2021-04-14 | Incyte Corp | Compuestos diólicos de aminopirazina como inhibidores de pi3k-y |
| US11046658B2 (en) | 2018-07-02 | 2021-06-29 | Incyte Corporation | Aminopyrazine derivatives as PI3K-γ inhibitors |
| US12384753B2 (en) * | 2021-08-20 | 2025-08-12 | Enanta Pharmaceuticals, Inc. | 17-beta-hydroxysteroid dehydrogenase type 13 inhibitors and methods of use thereof |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5366972A (en) | 1989-04-20 | 1994-11-22 | Boehringer Ingelheim Pharmaceuticals, Inc. | 5,11-dihydro-6H-dipyrido(3,2-B:2',3'-E)(1,4)diazepines and their use in the prevention or treatment of HIV infection |
| US5705499A (en) * | 1995-10-06 | 1998-01-06 | Boehringer Ingelheim Pharmaceuticals, Inc. | 8-arylalkyl- and 8-arylheteroalkyl-5,11-dihydro-6H-dipyrido 3,2-B:2',3'-e! 1!diazepines and their use in the treatment of HIV-1 infection |
| TWI270547B (en) | 2000-06-16 | 2007-01-11 | Boehringer Ingelheim Ca Ltd | Non-nucleoside reverse transcriptase inhibitors |
| US6716836B2 (en) | 2001-03-22 | 2004-04-06 | Boehringer Ingelheim (Canada) Ltd. | Non-nucleoside reverse transcriptase inhibitors |
| US6673791B2 (en) | 2001-07-30 | 2004-01-06 | Boehringer Ingelheim (Canada) Ltd. | Non-nucleoside reverse transcriptase inhibitors |
-
2003
- 2003-05-06 US US10/430,116 patent/US6806265B2/en not_active Expired - Lifetime
- 2003-05-13 MY MYPI20031796A patent/MY134646A/en unknown
- 2003-05-14 WO PCT/CA2003/000718 patent/WO2003097644A2/en not_active Ceased
- 2003-05-14 EP EP03724719A patent/EP1506195B1/en not_active Expired - Lifetime
- 2003-05-14 NZ NZ536736A patent/NZ536736A/en unknown
- 2003-05-14 MX MXPA04010409A patent/MXPA04010409A/es active IP Right Grant
- 2003-05-14 EA EA200401482A patent/EA009178B1/ru not_active IP Right Cessation
- 2003-05-14 DE DE60324418T patent/DE60324418D1/de not_active Expired - Lifetime
- 2003-05-14 PL PL03371663A patent/PL371663A1/xx not_active Application Discontinuation
- 2003-05-14 ES ES03724719T patent/ES2315492T3/es not_active Expired - Lifetime
- 2003-05-14 AT AT03724719T patent/ATE412653T1/de active
- 2003-05-14 AU AU2003229186A patent/AU2003229186A1/en not_active Abandoned
- 2003-05-14 BR BR0310033-2A patent/BR0310033A/pt not_active IP Right Cessation
- 2003-05-14 CN CNB038111187A patent/CN1318421C/zh not_active Expired - Fee Related
- 2003-05-14 PE PE2003000461A patent/PE20040365A1/es not_active Application Discontinuation
- 2003-05-14 IL IL16375303A patent/IL163753A0/xx unknown
- 2003-05-14 HR HR20041065A patent/HRP20041065A2/hr not_active Application Discontinuation
- 2003-05-14 UA UA20041210291A patent/UA79285C2/uk unknown
- 2003-05-14 RS YU98004A patent/RS98004A/sr unknown
- 2003-05-14 KR KR10-2004-7018428A patent/KR20050008716A/ko not_active Withdrawn
- 2003-05-14 CA CA002485916A patent/CA2485916C/en not_active Expired - Fee Related
- 2003-05-14 JP JP2004505376A patent/JP4230448B2/ja not_active Expired - Fee Related
- 2003-05-15 TW TW092113234A patent/TW200404071A/zh unknown
- 2003-05-15 UY UY27809A patent/UY27809A1/es not_active Application Discontinuation
- 2003-05-16 AR ARP030101708A patent/AR040027A1/es unknown
-
2004
- 2004-08-31 ZA ZA200406912A patent/ZA200406912B/xx unknown
- 2004-09-27 NO NO20044104A patent/NO20044104L/no unknown
- 2004-11-16 EC EC2004005432A patent/ECSP045432A/es unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR040027A1 (es) | Inhibidores de la transcriptasa inversa no nucleosidos | |
| AR037816A1 (es) | Fenil derivados sustituidos | |
| CO5170502A1 (es) | Derivados de 1-carboxi-n-cyclopropyl-4-(quinolin o naftil -4-iloxi) pirrolidin-2-carboxamide y sus composiciones farmaceuticas | |
| AR038703A1 (es) | Derivados de 5-feniltiazol y uso como inhibidor de quinasa p i 3 | |
| PE20090630A1 (es) | Derivados de indol 2-carboxi sustituidos y metodos para su utilizacion | |
| ES2506090T3 (es) | Inhibidores de la (ADP-ribosa) polimerasa | |
| EA200970172A1 (ru) | Пролекарство соединения амида коричной кислоты | |
| CO5031250A1 (es) | Compuesto farmaceutico | |
| EA200800476A1 (ru) | Макроциклические ингибиторы вируса гепатита с | |
| AR047050A1 (es) | Derivados de 1,3 diazol como inhibidores de aspartilproteasa. composiciones farmacéuticas | |
| ECSP055614A (es) | Compuestos quimicos | |
| EA200400893A1 (ru) | N-арил-2-оксазолидинон-5-карбоксамиды, их производные и их применение в качестве антибактериальных средств | |
| NO20053974L (no) | Tienopyrimidinforbindelser og anvendelse derav. | |
| CO5700733A2 (es) | Acidos aminocarboxilicos sustituidos | |
| CY1110263T1 (el) | Νεες ενωσεις ισοξαζολης και θειαζολης και η χρηση τους ως φαρμακα | |
| EA200100061A1 (ru) | Производные фталазина в качестве ингибиторов фосфодиэстеразы 4 | |
| EA201100009A1 (ru) | Соединения 1,2-бензизотиазола, полезные для борьбы с животными-вредителями | |
| PE20020750A1 (es) | Derivados de pirazol | |
| PE20001063A1 (es) | Nuevos agentes antibacterianos de isoxazolinona | |
| AR040411A1 (es) | Inhibidores de la arn polimerasa dependiente de arn del virus de la hepatitis c y composiciones y tratamientos que los usan | |
| CO5580762A2 (es) | Analogos de lipoxina a4 | |
| AR060334A1 (es) | Derivados de benzimidazol | |
| CO5601039A2 (es) | Oxazolidinonas de indolona y derivados de las mismas | |
| DE69923744D1 (de) | 1,3,8-Triazaspiro[4,5] decanon Verbindungen als orl1-receptor Agonisten | |
| DE60220997D1 (de) | N-aryl-substituiertes cyclisches aminderivat und medizin, die dieses als wirkstoff enthält |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FB | Suspension of granting procedure |